Free Trial
CVE:SVS

Solarvest BioEnergy (SVS) Stock Price, News & Analysis

Solarvest BioEnergy logo
C$0.02 0.00 (0.00%)
As of 09/5/2023

About Solarvest BioEnergy Stock (CVE:SVS)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.03
C$0.03
52-Week Range
C$0.01
C$0.14
Volume
3,159 shs
Average Volume
77,594 shs
Market Capitalization
C$1.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.

Receive SVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solarvest BioEnergy and its competitors with MarketBeat's FREE daily newsletter.

SVS Stock News Headlines

“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
Solarvest Sells PEI Facility
See More Headlines

SVS Stock Analysis - Frequently Asked Questions

Solarvest BioEnergy's stock was trading at C$0.03 on January 1st, 2025. Since then, SVS shares have increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here
.

Shares of SVS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solarvest BioEnergy investors own include FSD Pharma (HUGE), Nemaska Lithium (NMX), Intercept Pharmaceuticals (ICPT), Sernova (SVA), Routemaster Capital Inc. (RM.V) (RM), IGEN Networks (IGEN) and Clean Energy Pathways (CPWY).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SVS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.26 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$740.00
Cash Flow
C$0.00 per share
Price / Cash Flow
55.00
Book Value
C($0.10) per share
Price / Book
-0.25

Miscellaneous

Free Float
N/A
Market Cap
C$1.52 million
Optionable
Not Optionable
Beta
1.50
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:SVS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners